{"database": "openregs", "table": "dockets", "is_view": false, "human_description_en": "where agency_id = \"DEA\" and docket_type = \"Rulemaking\" sorted by last_modified descending", "rows": [["DEA_FRDOC_0001", "DEA", "Recently Posted DEA Rules and Notices", "Rulemaking", "2026-03-10T12:55:22Z", "0b0000648025b551"], ["DEA-2023-0057", "DEA", "Definition of \u2018\u2018Cannabimimetic Agents\u2019\u2019 and Assignment of an Administration Controlled Substances Code Number for All \u2018\u2018Cannabimimetic Agents\u2019\u2019 (DEA368)", "Rulemaking", "2026-01-20T18:44:45Z", "0b00006485945c83"], ["DEA-2026-0133", "DEA", "Schedules of Controlled Substances: Placement of 2-Fluorodeschloroketamine in Schedule I (DEA1442)", "Rulemaking", "2026-01-20T18:39:12Z", "0b000064b9161bed"], ["DEA-2025-0075", "DEA", "Placement of 4-Fluoroamphetamine in Schedule I (DEA1180)", "Rulemaking", "2026-01-16T15:16:59Z", "0b000064b8dc49a1"], ["DEA-2023-0029", "DEA", "Telemedicine Prescribing of Controlled Substances (DEA407)", "Rulemaking", "2026-01-12T22:00:12Z", "0b00006485728671"], ["DEA-2024-0118", "DEA", "Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I (DEA1337)", "Rulemaking", "2026-01-12T21:58:59Z", "0b00006486732eab"], ["DEA-2023-0147", "DEA", "Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I (DEA1143)", "Rulemaking", "2026-01-05T20:10:17Z", "0b0000648613cdb2"], ["DEA-2025-0852", "DEA", "Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511)", "Rulemaking", "2026-01-05T13:16:32Z", "0b000064b90c539c"], ["DEA-2025-0918", "DEA", "Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604)", "Rulemaking", "2026-01-05T13:16:18Z", "0b000064b90dd26c"], ["DEA-2025-0654", "DEA", "Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026", "Rulemaking", "2025-12-16T20:07:46Z", "0b000064b909f13a"], ["DEA-2025-0885", "DEA", "Schedules of Controlled Substances: Placement of Bromazolam in Schedule I  (DEA1420)", "Rulemaking", "2025-12-15T15:47:54Z", "0b000064b90d3674"], ["DEA-2025-0555", "DEA", "Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356)", "Rulemaking", "2025-12-11T14:41:46Z", "0b000064b8fefe20"], ["DEA-2024-0144", "DEA", "Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246)", "Rulemaking", "2025-11-19T21:13:12Z", "0b00006486891ffe"], ["DEA-2025-0557", "DEA", "Designation of P2P Methyl Glycidic Acid as a List I Chemical (DEA1395)", "Rulemaking", "2025-11-04T12:07:45Z", "0b000064b8fefe8d"], ["DEA-2025-0588", "DEA", "Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I (DEA1494)", "Rulemaking", "2025-10-16T23:33:17Z", "0b000064b9030281"], ["DEA-2025-0192", "DEA", "Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance  (DEA1390)", "Rulemaking", "2025-10-16T23:28:47Z", "0b000064b8ec6630"], ["DEA-2023-0016", "DEA", "Controlled Substances Ordering System Modernization (DEA732)", "Rulemaking", "2025-10-02T21:31:46Z", "0b0000648562ccb3"], ["DEA-2025-0558", "DEA", "Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction (DEA1111)", "Rulemaking", "2025-10-02T21:30:04Z", "0b000064b8fefe93"], ["DEA-2024-0148", "DEA", "Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457)", "Rulemaking", "2025-10-02T21:28:47Z", "0b00006486894bb0"], ["DEA-2025-0556", "DEA", "Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical", "Rulemaking", "2025-10-02T21:22:21Z", "0b000064b8fefe24"], ["DEA-2024-0120", "DEA", "Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025", "Rulemaking", "2025-09-19T16:15:52Z", "0b00006486783c5d"], ["DEA-2022-0145", "DEA", "Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989)", "Rulemaking", "2025-08-27T12:33:24Z", "0b0000648554cfe6"], ["DEA-2024-0026", "DEA", "Placement of 2-Methyl AP-237 in Schedule I (DEA1245)", "Rulemaking", "2025-07-28T18:22:10Z", "0b00006486484632"], ["DEA-2023-0148", "DEA", "Destruction Alternatives to Incineration (DEA1144)", "Rulemaking", "2025-07-28T18:21:23Z", "0b0000648618d50c"], ["DEA-2025-0078", "DEA", "Three specific fentanyl-related substances (para-bromofentanyl, para-fluoroacetyl fentanyl, and para-methyl acetyl fentanyl) (DEA1484)", "Rulemaking", "2025-07-28T18:18:20Z", "0b000064b8dd586c"], ["DEA-2023-0138", "DEA", "Designation of Propionyl Chloride as a List I Chemical (DEA1189)", "Rulemaking", "2025-07-10T12:04:03Z", "0b000064860bbba7"], ["DEA-2025-0081", "DEA", "Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl] piperidine) in Schedule I (DEA1146)", "Rulemaking", "2025-07-10T11:56:30Z", "0b000064b8ddd142"], ["DEA-2023-0098", "DEA", "Implementation of the Designer Anabolic Steroid Control Act of 2014 (DEA481)", "Rulemaking", "2025-07-07T16:45:39Z", "0b00006485d9c470"], ["DEA-2021-0003", "DEA", "Suspicious Orders of Controlled Substances", "Rulemaking", "2025-06-05T16:32:03Z", "0b000064849e1a2e"], ["DEA-2023-0028", "DEA", "Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948)", "Rulemaking", "2025-06-02T20:11:54Z", "0b0000648572859f"], ["DEA-2024-0059", "DEA", "Schedules of Controlled Substances: Rescheduling of Marijuana", "Rulemaking", "2025-02-21T15:51:02Z", "0b0000648656cd99"], ["DEA-2023-0168", "DEA", "Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I (DEA1156)", "Rulemaking", "2025-02-21T15:50:53Z", "0b00006486330ce3"], ["DEA-2023-0150", "DEA", "Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024 (DEA1228)", "Rulemaking", "2025-02-21T15:50:43Z", "0b000064861df091"], ["DEA-2024-0134", "DEA", "Control of Phenethyl Bromide as a List I Chemical (DEA1282)", "Rulemaking", "2025-01-07T09:13:06Z", "0b0000648683d06e"], ["DEA-2021-0031", "DEA", "Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I", "Rulemaking", "2024-10-25T14:56:30Z", "0b00006484ea7ed9"], ["DEA-2023-0129", "DEA", "Placement of Ethylphenidate in Schedule I (DEA1142)", "Rulemaking", "2024-10-24T10:27:34Z", "0b00006485fe80fd"], ["DEA-2023-0149", "DEA", "Placement of Zuranolone in Schedule IV (DEA1258)", "Rulemaking", "2024-09-03T18:47:04Z", "0b000064861a0975"], ["DEA-2022-0058", "DEA", "Providing CS to Ocean Vessels, Aircraft, and Other Entities", "Rulemaking", "2024-08-26T13:13:33Z", "0b0000648514e942"], ["DEA-2024-0009", "DEA", "Conforming Amendment Regarding the Veterinary Medicine Mobility Act of 2014", "Rulemaking", "2024-08-26T13:13:33Z", "0b000064863e8464"], ["DEA-2021-0027", "DEA", "Regulation of Telepharmacy Practice", "Rulemaking", "2024-08-26T13:06:55Z", "0b00006484e57207"], ["DEA-2020-0023", "DEA", "Implementation of the Agricultural Improvement Act", "Rulemaking", "2024-08-26T13:03:33Z", "0b0000648481bb3b"], ["DEA-2020-0031", "DEA", "Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act:  Dispensing and Administering Controlled Substances for Medication-Assisted Treatment", "Rulemaking", "2024-08-26T13:03:21Z", "0b00006484946331"], ["DEA-2020-0029", "DEA", "Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017", "Rulemaking", "2024-08-26T13:02:59Z", "0b000064848b8dbc"], ["DEA-2010-0010", "DEA", "Electronic Prescriptions for Controlled Substances", "Rulemaking", "2024-08-26T13:00:45Z", "0b00006480acce59"], ["DEA-2021-0005", "DEA", "Amending Regulations to Require Online Submission of Applications for and Renewals of DEA Registration", "Rulemaking", "2024-07-12T12:24:57Z", "0b000064849e58a9"], ["DEA-2021-0009", "DEA", "MAPA - Designation as List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine", "Rulemaking", "2024-06-11T01:13:26Z", "0b00006484aeb507"], ["DEA-2022-0120", "DEA", "Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023", "Rulemaking", "2024-02-12T10:32:02Z", "0b000064854169b8"], ["DEA-2023-0169", "DEA", "Specific Listing for Three Currently Controlled Schedule I Substances (DEA1222)", "Rulemaking", "2024-02-12T10:29:05Z", "0b00006486330ce7"], ["DEA-2023-0049", "DEA", "Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I (DEA1006)", "Rulemaking", "2023-12-12T10:13:43Z", "0b000064858c4370"], ["DEA-2023-0058", "DEA", "Placement of Nine Specific Fentanyl Related Substances in Schedule I (DEA1036)", "Rulemaking", "2023-12-07T08:20:24Z", "0b00006485946204"], ["DEA-2023-0146", "DEA", "Additions to Listing of Exempt Chemical Mixtures (DEA1118)", "Rulemaking", "2023-11-28T08:25:33Z", "0b00006486128852"], ["DEA-2023-0059", "DEA", "Designation as List I Chemicals: Halides of 4-Anilinopiperidine (DEA1098)", "Rulemaking", "2023-10-31T09:33:44Z", "0b00006485948761"], ["DEA-2023-0106", "DEA", "Dispensing of Narcotic Drugs to Relieve Acute Withdrawal Symptoms of Opioid Use Disorder (DEA702)", "Rulemaking", "2023-09-22T15:24:15Z", "0b00006485e04d45"], ["DEA-2019-0013", "DEA", "Management of Quotas for Controlled Substances and List I Chemicals", "Rulemaking", "2023-08-31T08:33:18Z", "0b000064840ecddb"], ["DEA-2021-0026", "DEA", "Transfer of Electronic Prescriptions for Controlled Substances for Initial Filling", "Rulemaking", "2023-07-27T17:35:24Z", "0b00006484e3d5e0"], ["DEA-2020-0035", "DEA", "Partial Filling of Prescriptions for Schedule II Controlled Substances", "Rulemaking", "2023-07-21T08:48:17Z", "0b0000648498d6d9"], ["DEA-2020-0038", "DEA", "Schedules of Controlled Substances: Placement of Brorphine in Schedule I", "Rulemaking", "2023-07-19T11:16:28Z", "0b000064849c2716"], ["DEA-2020-0022", "DEA", "Reporting of Theft or Significant Loss of Controlled Substances", "Rulemaking", "2023-06-22T11:34:57Z", "0b000064847f5109"], ["DEA-2023-0056", "DEA", "Specific Listing for Eutylone, a Currently Controlled Schedule I Substance (DEA1003)", "Rulemaking", "2023-04-20T11:59:12Z", "0b0000648591cd29"], ["DEA-2022-0102", "DEA", "Designation of 4-Piperidone as a List I Chemical (DEA951)", "Rulemaking", "2023-04-14T08:25:52Z", "0b0000648532a5f2"], ["DEA-2021-0013", "DEA", "Schedules of Controlled Substances:  Placement of Methiopropamine in Schedule I", "Rulemaking", "2023-01-03T10:35:25Z", "0b00006484d9d986"], ["DEA-2022-0137", "DEA", "Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023", "Rulemaking", "2022-12-02T09:49:04Z", "0b00006485511272"], ["DEA-2020-0027", "DEA", "Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration", "Rulemaking", "2022-11-30T08:08:19Z", "0b000064848ac79e"], ["DEA-2021-0012", "DEA", "Schedules of Controlled Substances: Placement of Mesocarb in Schedule I", "Rulemaking", "2022-11-22T08:27:38Z", "0b00006484c6c390"], ["DEA-2021-0025", "DEA", "Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control", "Rulemaking", "2022-11-21T08:32:10Z", "0b00006484e16b15"], ["DEA-2020-0015", "DEA", "Schedules of Controlled Substances: Placement of Zipeprol in Schedule I", "Rulemaking", "2022-11-21T08:31:59Z", "0b000064846acf98"], ["DEA-2021-0011", "DEA", "Schedules of Controlled Substances: Placement of Amineptine in Schedule I", "Rulemaking", "2022-11-17T08:07:18Z", "0b00006484c12765"], ["DEA-2022-0134", "DEA", "Specific Listing for 1-boc-4-AP, a Currently Controlled List I Chemical (DEA1046)", "Rulemaking", "2022-11-14T08:34:19Z", "0b0000648549e00d"], ["DEA-2022-0133", "DEA", "Technical Correction to Regulation Regarding Registration Exception for Officials", "Rulemaking", "2022-11-07T09:10:13Z", "0b000064854931e9"], ["DEA-2021-0014", "DEA", "Aggregate Production  Quotas for Schedule I and II Controlled  Substances and Assessment of  Annual Needs for the List I Chemicals  Ephedrine, Pseudoephedrine, and  Phenylpropanolamine for 2022", "Rulemaking", "2022-11-01T08:26:20Z", "0b00006484dc7d4f"], ["DEA-2022-0025", "DEA", "Schedules of Controlled Substances: Placement of Daridorexant in Schedule IV", "Rulemaking", "2022-09-30T08:21:23Z", "0b00006484fff734"], ["DEA-2022-0026", "DEA", "Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I", "Rulemaking", "2022-09-13T08:49:45Z", "0b0000648500a875"], ["DEA-2022-0001", "DEA", "Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I", "Rulemaking", "2022-07-27T08:21:18Z", "0b00006484f21216"], ["DEA-2021-0010", "DEA", "Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV", "Rulemaking", "2022-06-24T08:22:18Z", "0b00006484b1ab60"], ["DEA-2022-0027", "DEA", "Schedules of Controlled Substances: Exempted Prescription Products - Butalbital products", "Rulemaking", "2022-06-07T08:46:48Z", "0b0000648500f7d4"], ["DEA-2021-0030", "DEA", "Schedules of Controlled Substances: Placement of Methoxetamine in Schedule I", "Rulemaking", "2022-06-06T09:58:53Z", "0b00006484ea7ed5"], ["DEA-2019-0002", "DEA", "Schedules of Controlled Substances: Placement of 5F-EDMBPINACA,\n5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in\nSchedule I", "Rulemaking", "2022-04-08T08:28:19Z", "0b00006483b714a4"], ["DEA-2018-0002", "DEA", "Implementation of the Provision of the Comprehensive Addiction and Recovery Act of 2016 Relating to the Dispensing of Narcotic Drugs for Opioid Use Disorder", "Rulemaking", "2022-04-02T01:07:02Z", "0b00006482e4b773"], ["DEA-2018-0009", "DEA", "Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl into Schedule I", "Rulemaking", "2022-04-02T01:07:02Z", "0b00006483254c72"], ["DEA-2014-0005", "DEA", "Schedules of Controlled Substances:  Rescheduling of Hydrocodone Combination Products from Schedule III to Schedule II", "Rulemaking", "2022-03-22T11:18:07Z", "0b000064815b6cb3"], ["DEA-2018-0004", "DEA", "Schedules of Controlled Substances:\nPlacement of Butyryl Fentanyl and\nU\u201347700 Into Schedule I (DEA-478)", "Rulemaking", "2022-03-22T11:16:58Z", "0b0000648319a695"], ["DEA-2021-0024", "DEA", "Adding Space Force to DEA Regulations", "Rulemaking", "2021-12-13T15:38:43Z", "0b00006484e0408e"], ["DEA-2020-0036", "DEA", "Supplier's Registration Number on the Single-Sheet DEA Form 222", "Rulemaking", "2021-12-13T15:35:55Z", "0b000064849af553"], ["DEA-2020-0005", "DEA", "Registration Requirements for Narcotic Treatment Programs with Mobile Components", "Rulemaking", "2021-12-13T15:33:40Z", "0b000064843b54e5"], ["DEA-2013-0002", "DEA", "Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV", "Rulemaking", "2021-12-02T01:01:29Z", "0b000064812438ed"], ["DEA-2013-0009", "DEA", "Schedules of Controlled Substances: Placement of Perampanel into Schedule III", "Rulemaking", "2021-12-02T01:01:29Z", "0b000064814577a1"], ["DEA-2013-0010", "DEA", "Schedules of Controlled Substances:  Placement of Tramadol into Schedule IV", "Rulemaking", "2021-12-02T01:01:29Z", "0b0000648146f62c"], ["DEA-2013-0011", "DEA", "Schedules of Controlled Substances: Temporary Placement of Three Synthetic \r\nPhenethylamines into Schedule I", "Rulemaking", "2021-12-02T01:01:29Z", "0b0000648147da34"], ["DEA-2018-0006", "DEA", "Schedules of Controlled Substances: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act, DEA-345", "Rulemaking", "2021-12-02T01:01:29Z", "0b0000648321a7cd"], ["DEA-2019-0007", "DEA", "Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control", "Rulemaking", "2021-12-02T01:01:29Z", "0b00006483eaf996"], ["DEA-2019-0003", "DEA", "Interlocutory Appeals in Administrative\nHearings", "Rulemaking", "2021-12-02T01:00:59Z", "0b00006483c17ccc"], ["DEA-2019-0004", "DEA", "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I", "Rulemaking", "2021-12-02T01:00:59Z", "0b00006483c8ada8"], ["DEA-2019-0009", "DEA", "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I", "Rulemaking", "2021-12-02T01:00:59Z", "0b00006483f91d72"], ["DEA-2019-0010", "DEA", "Listing of Noroxymorphone in the Code of Federal Regulations and Assignment of a Controlled Substances Code Number", "Rulemaking", "2021-12-02T01:00:59Z", "0b00006483f94f85"], ["DEA-2019-0011", "DEA", "Schedules of Controlled Substances: Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals", "Rulemaking", "2021-12-02T01:00:59Z", "0b00006483f94f89"], ["DEA-2019-0012", "DEA", "Schedules of Controlled Substances: Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as Schedule II", "Rulemaking", "2021-12-02T01:00:59Z", "0b00006483f94f8d"], ["DEA-2019-0014", "DEA", "Schedules of Controlled Substances: Placement of Cyclopropyl Fentanyl, Methoxyacetyl fentanyl, ortho-Fluorofentanyl, and para-Fluorobutyryl Fentanyl in Schedule I", "Rulemaking", "2021-12-02T01:00:59Z", "0b000064841fc599"], ["DEA-2020-0004", "DEA", "Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control", "Rulemaking", "2021-12-02T01:00:59Z", "0b00006484322c50"], ["DEA-2020-0014", "DEA", "Technical Correction to Regulation Regarding Registration", "Rulemaking", "2021-12-02T01:00:59Z", "0b000064844bd097"], ["DEA-2020-0017", "DEA", "Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I", "Rulemaking", "2021-12-02T01:00:59Z", "0b000064846f9f29"]], "truncated": false, "filtered_table_rows_count": 261, "expanded_columns": [], "expandable_columns": [], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, title, docket_type, last_modified, object_id from dockets where \"agency_id\" = :p0 and \"docket_type\" = :p1 order by last_modified desc limit 101", "params": {"p0": "DEA", "p1": "Rulemaking"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/dockets.json?agency_id=DEA&docket_type=Rulemaking", "results": [{"value": "DEA", "label": "DEA", "count": 261, "toggle_url": "https://regs.datadawn.org/openregs/dockets.json?docket_type=Rulemaking", "selected": true}], "truncated": false}, "docket_type": {"name": "docket_type", "type": "column", "hideable": false, "toggle_url": "/openregs/dockets.json?agency_id=DEA&docket_type=Rulemaking", "results": [{"value": "Rulemaking", "label": "Rulemaking", "count": 261, "toggle_url": "https://regs.datadawn.org/openregs/dockets.json?agency_id=DEA", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "last_modified", "type": "date", "toggle_url": "https://regs.datadawn.org/openregs/dockets.json?agency_id=DEA&docket_type=Rulemaking&_facet_date=last_modified"}], "next": "2021-12-02T01~3A00~3A59Z,DEA-2020-0017", "next_url": "https://regs.datadawn.org/openregs/dockets.json?agency_id=DEA&docket_type=Rulemaking&_next=2021-12-02T01~3A00~3A59Z%2CDEA-2020-0017&_sort_desc=last_modified", "private": false, "allow_execute_sql": true, "query_ms": 643.8916439656168, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}